The National Institutes of Health has named OHSU’s Oregon Clinical & Translational Research Institute a recipient of 2017 Clinical and Translational Science Award (CTSA) grant. OCTRI was an original recipient of the program in 2006, and the new award provides more than $37 million in federal funding to support the Institute’s work over the next five years.
OCTRI helps accelerate the translation of research into clinical use, medical practice and health policy, with the goal of improving the health of the public.
“Our support for clinical trials, translational science, pilot studies, career development and study design has made OCTRI an integral part of the OHSU research community,” said David Ellison, M.D., director of OCTRI. “We look forward to continuing this important work with OHSU investigators.”
OCTRI career development initiatives have educated more than 600 young investigators since 2006. The initiatives include the KL2 Mentored Career Development program for faculty scholars and the TL1 program for predoctoral and postdoctoral training in translational research.
Pilot study funding from OCTRI supports innovation and collaboration. The Biomedical Innovation Program, an OCTRI collaboration with OHSU Technology Transfer and Business Development, provides funding up to $60,000, project management, and access to project-specific mentors and experts. The new Team Science Awards will help advance novel, collaborative research initiatives at OHSU.
OCTRI supports human subjects research through the Clinical and Translational Research Center, with a full range of research support, including informatics services, data management and analysis, and regulatory assistance. The recently formed Clinical Research Development Team provides assistance to investigators with integrated protocol design support, rapid study start-up, recruitment consultation, and solution-based support of ongoing research.
OCTRI is also a key partner in a new CTSA collaborative initiative—the Trial Innovation Network. TIN provides resources and infrastructure for investigators planning and conducting multi-site research, including support for single IRB and master contracting models. The goal is to not only execute trials better, faster and more cost-efficiently as part of a national laboratory to study, understand and innovate the process of conducting clinical trials.
The CTSA program’s renewed funding provides OCTRI with the resources to expand its services, education, and mentorship to OHSU investigators.